Paola Gazzaniga

Pubblicazioni

Titolo Pubblicato in Anno
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients JCO PRECISION ONCOLOGY 2021
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors ANNALS OF ONCOLOGY 2021
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights ONCOLOGY 2020
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer ONCOTARGET 2020
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer EUROPEAN UROLOGY ONCOLOGY 2020
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients CANCERS 2020
Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy. JOURNAL OF THE NATIONAL CANCER INSTITUTE 2020
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer CANCERS 2019
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial THE ONCOLOGIST 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test JAMA ONCOLOGY 2019
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion Cancer Immunosurveillance 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer EUROPEAN JOURNAL OF CANCER 2019
Circulating tumor cells in right-and left-sided colorectal cancer CANCERS 2019
EpCAMlow circulating tumor cells: Gold in the waste DISEASE MARKERS 2019
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer FRONTIERS IN ONCOLOGY 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test JAMA ONCOLOGY 2019
EGFR inhibitor as second-line therapy in a patient with mutant RAS metastatic colorectal cancer: circulating tumor DNA to personalize treatment JCO PRECISION ONCOLOGY 2018
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma ANALYTICAL CELLULAR PATHOLOGY 2018

ERC

  • LS4_12

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

liquid biopsy of cancer, circulating tumor DNA, circulating tumor cells

Keywords

liquid biopsy

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma